Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Invus Public Equities, LP

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorMar 13, 2024Option Exercise$108.501,150,922124,875,0371,150,922Mar 13, 2024, 09:22 PM
SRRKScholar Rock Holding CorpInvus Public Equities, L.P.10% OwnerOct 12, 2023Buy$6.862,199,93115,086,73511,259,438Oct 16, 2023, 05:46 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 05, 2023Buy$2.6027,775,05072,215,12778,634,381Jun 05, 2023, 04:46 PM
SRRKScholar Rock Holding CorpInvus Public Equities, L.P.10% OwnerApr 28, 2023Buy$6.4331,557202,8459,059,507May 02, 2023, 09:00 PM
GLYCGLYCOMIMETICS INCInvus Public Equities, L.P.10% OwnerFeb 24, 2023Buy$1.70100,000170,0008,589,064Feb 28, 2023, 05:33 PM
GLYCGLYCOMIMETICS INCInvus Public Equities, L.P.10% OwnerFeb 22, 2023Buy$1.79150,000268,9958,289,064Feb 23, 2023, 06:23 PM
GLYCGLYCOMIMETICS INCInvus Public Equities, L.P.10% OwnerFeb 23, 2023Buy$1.75200,000350,7608,489,064Feb 23, 2023, 06:23 PM
GLYCGLYCOMIMETICS INCInvus Public Equities, L.P.10% OwnerFeb 21, 2023Buy$1.8550,00092,5008,139,064Feb 23, 2023, 06:23 PM
GLYCGLYCOMIMETICS INCInvus Public Equities, L.P.10% OwnerFeb 16, 2023Buy$1.68315,266531,1297,889,064Feb 17, 2023, 05:29 PM
GLYCGLYCOMIMETICS INCInvus Public Equities, L.P.10% OwnerFeb 17, 2023Buy$1.71200,000341,0008,089,064Feb 17, 2023, 05:29 PM
GLYCGLYCOMIMETICS INCInvus Public Equities, L.P.10% OwnerFeb 15, 2023Buy$2.161,000,0002,155,8007,573,798Feb 17, 2023, 05:29 PM
GLYCGLYCOMIMETICS INCInvus Public Equities, L.P.10% OwnerFeb 09, 2023Buy$3.2411,45137,1236,573,798Feb 13, 2023, 05:45 PM
SRRKScholar Rock Holding CorpInvus Public Equities, L.P.10% OwnerJan 09, 2023Sale$9.481,09410,3739,027,950Jan 11, 2023, 08:30 PM
SRRKScholar Rock Holding CorpInvus Public Equities, L.P.10% OwnerJan 05, 2023Buy$9.3348,774455,0919,029,044Jan 09, 2023, 05:22 PM
SRRKScholar Rock Holding CorpInvus Public Equities, L.P.10% OwnerOct 25, 2022Buy$8.04130,2651,047,3838,980,270Oct 27, 2022, 04:36 PM
SRRKScholar Rock Holding CorpInvus Public Equities, L.P.10% OwnerOct 04, 2022Buy$7.8966,000520,7608,850,005Oct 07, 2022, 04:30 PM
SRRKScholar Rock Holding CorpInvus Public Equities, L.P.10% OwnerOct 03, 2022Buy$7.0333,971238,7898,784,005Oct 07, 2022, 04:30 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorAug 05, 2022Buy$2.502,426,0706,065,17550,859,331Aug 09, 2022, 04:46 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorAug 01, 2022Buy$2.5016,173,80040,434,50048,433,261Aug 01, 2022, 04:15 PM
OMGAOmega Therapeutics, Inc.Invus Public Equities, L.P.10% OwnerJul 30, 2021Buy$16.1475,0001,210,34275,000Aug 03, 2021, 05:16 PM
OMGAOmega Therapeutics, Inc.Invus Public Equities, L.P.10% OwnerAug 03, 2021Buy$17.00875,00014,875,0002,273,530Aug 03, 2021, 05:16 PM
SEERSeer, Inc.Invus Public Equities, L.P.10% OwnerFeb 01, 2021Sale$64.15252,54516,201,5195,588,366Feb 03, 2021, 09:52 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorDec 16, 2020Buy$3.2010,937,50035,000,00132,259,461Dec 17, 2020, 02:39 PM
SEERSeer, Inc.Invus Public Equities, L.P.10% OwnerDec 08, 2020Buy$19.00790,00015,010,0005,840,911Dec 10, 2020, 04:15 PM
SQZSQZ Biotechnologies CoInvus Public Equities, L.P.10% OwnerNov 03, 2020Buy$16.00465,0007,440,0001,606,308Nov 03, 2020, 08:00 PM
GBIOGeneration Bio Co.Invus Public Equities, L.P.10% OwnerJun 16, 2020Buy$19.00800,00015,200,0002,814,191Jun 18, 2020, 06:01 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 27, 2018Buy$12.54125,1141,568,4423,458,490Jun 29, 2018, 04:23 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 28, 2018Buy$12.4557,724718,9353,516,214Jun 29, 2018, 04:23 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 22, 2018Buy$13.3625,461340,0903,105,112Jun 26, 2018, 05:32 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 25, 2018Buy$12.95228,2642,955,0833,333,376Jun 26, 2018, 05:32 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 20, 2018Buy$13.2812,391164,6133,028,051Jun 21, 2018, 05:55 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 21, 2018Buy$13.2751,600684,6133,079,651Jun 21, 2018, 05:55 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 19, 2018Buy$13.458,982120,8193,015,660Jun 21, 2018, 05:55 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 14, 2018Buy$12.669,200116,4622,970,094Jun 18, 2018, 06:56 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 18, 2018Buy$13.0636,584477,9373,006,678Jun 18, 2018, 06:56 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 11, 2018Buy$12.7598,6261,257,4522,853,871Jun 12, 2018, 06:10 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 12, 2018Buy$12.83107,0231,373,2442,960,894Jun 12, 2018, 06:10 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 08, 2018Buy$12.8929,747383,4272,755,245Jun 12, 2018, 06:10 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 05, 2018Buy$12.45173,1212,156,1872,572,980Jun 07, 2018, 07:37 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 06, 2018Buy$12.5895,0791,196,3702,668,059Jun 07, 2018, 07:37 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 07, 2018Buy$12.9357,439742,5082,725,498Jun 07, 2018, 07:37 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 04, 2018Buy$12.24121,8031,490,5762,399,859Jun 04, 2018, 05:31 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorMay 31, 2018Buy$11.62147,3391,712,0502,130,717Jun 04, 2018, 05:31 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorJun 01, 2018Buy$12.22147,3391,800,0412,278,056Jun 04, 2018, 05:31 PM
SRRKScholar Rock Holding CorpInvus Public Equities, L.P.10% OwnerMay 29, 2018Buy$14.00450,0006,300,000450,000May 31, 2018, 09:41 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorMay 25, 2018Buy$9.62138,7001,334,9741,688,700May 30, 2018, 08:53 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorMay 29, 2018Buy$9.84147,3391,450,4201,836,039May 30, 2018, 08:53 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorMay 30, 2018Buy$10.32147,3391,521,0251,983,378May 30, 2018, 08:53 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorNov 15, 2017Buy$10.21130,7271,334,3961,500,000Nov 17, 2017, 08:09 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorNov 17, 2017Buy$9.8550,000492,5001,550,000Nov 17, 2017, 08:09 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorNov 10, 2017Buy$9.74145,6801,418,384939,007Nov 14, 2017, 07:32 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorNov 13, 2017Buy$9.75215,1332,097,9341,154,140Nov 14, 2017, 07:32 PM
LXRXLEXICON PHARMACEUTICALS, INC.Invus Public Equities, L.P.DirectorNov 14, 2017Buy$9.47215,1332,037,8471,369,273Nov 14, 2017, 07:32 PM
LXRXLEXICON PHARMACEUTICALS, INC./DEInvus Public Equities, L.P.DirectorNov 26, 2014Buy$1.00149,253,731149,999,999149,253,731Nov 26, 2014, 07:19 PM
LXRXLEXICON PHARMACEUTICALS, INC./DEInvus Public Equities, L.P.DirectorOct 23, 2012Buy$2.253,000,0006,750,000283,154,744Oct 25, 2012, 05:21 PM
LXRXLEXICON PHARMACEUTICALS, INC./DEInvus Public Equities, LPDirectorDec 22, 2011Option Exercise$1.13115,004,247129,954,799250,372,135Dec 27, 2011, 05:26 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe